View Document Preview and Link Document Date: 2014-11-10 12:52:07 Open Document File Size: 999,84 KB Share Result on Facebook
City Rochester / / Continent North America / / Country Senegal / Benin / / Facility Mayo Clinic / Blood Institute / Sickle Cell Center / Medical College of Georgia / / IndustryTerm Treatment of Sickle Cell Disease / Treatment for Sickle Cell Disease / Care of Sickle Cell Disease / Treatment for Patients With Sickle Cell Disease / / MedicalCondition sepsis/infection / marrow depression / HIV / disease / liver failure / sickle cell anemia / acute chest syndrome / stroke / pulmonary hypertension / fever / pain / hepatic failure / lymphadenopathy / renal disease / Sickle Cell Disease / Quality deficiency / aseptic necrosis / infection / renal failure / rash / hepatic disease / / MedicalTreatment contraception / / Organization Data Coordinating Center / Knowledge and Encounter Research Unit / Medical College of Georgia / National Heart / Lung / and Blood Institute / / Person Al-Jam / D. Anas Shahrour Larry Prokop / M. Hassan Murad / P.H. Ahmad Hazem / B.A. Rebecca Mullan / Victor M. Montori / Black Hispanic / / Position Author / Hb / Sickle Cell Disease Author / Sickle Cell Disease Author / year Patient groups / physician / / Product Hydroxyurea / / ProvinceOrState Georgia / / Technology predetermined protocol / Genotype / followed prospectively using a predetermined protocol / / URL http / SocialTag 
Hydroxyurea for Sickle Cell Disease: A Systematic Review of Benefits, Harms, and Barriers of Utilization, 2012 Prepared for the National Heart, Lung, and Blood Institute (NHLBI) Prepared by the Knowledge and Encounter R